ARTIVION INC (AORT) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:AORT - US2289031005 - Common Stock
46.89 USD
-0.29 (-0.61%)
46.89 USD
0 (0%)
Taking everything into account, AORT scores 5 out of 10 in our fundamental rating. AORT was compared to 185 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and the financial health of AORT get a neutral evaluation. Nothing too spectacular is happening here. AORT is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year AORT has reported negative net income.
AORT had a positive operating cash flow in the past year.
In the past 5 years AORT always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: AORT reported negative operating cash flow in multiple years.
1.2 Ratios
Looking at the Return On Assets, with a value of -1.06%, AORT is in the better half of the industry, outperforming 71.35% of the companies in the same industry.
With a decent Return On Equity value of -2.08%, AORT is doing good in the industry, outperforming 71.35% of the companies in the same industry.
AORT's Return On Invested Capital of 2.28% is fine compared to the rest of the industry. AORT outperforms 68.65% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.06% | ||
| ROE | -2.08% | ||
| ROIC | 2.28% |
ROA(3y)-2.68%
ROA(5y)-2.4%
ROE(3y)-7.46%
ROE(5y)-6.47%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Operating Margin, with a value of 5.26%, AORT is in the better half of the industry, outperforming 69.73% of the companies in the same industry.
In the last couple of years the Operating Margin of AORT has grown nicely.
The Gross Margin of AORT (64.50%) is better than 65.95% of its industry peers.
In the last couple of years the Gross Margin of AORT has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.26% | ||
| PM (TTM) | N/A | ||
| GM | 64.5% |
OM growth 3Y34.21%
OM growth 5Y6.88%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.05%
GM growth 5Y-0.68%
2. Health
2.1 Basic Checks
AORT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
AORT has more shares outstanding than it did 1 year ago.
The number of shares outstanding for AORT has been increased compared to 5 years ago.
Compared to 1 year ago, AORT has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 4.02 indicates that AORT is not in any danger for bankruptcy at the moment.
The Altman-Z score of AORT (4.02) is better than 74.05% of its industry peers.
The Debt to FCF ratio of AORT is 12.48, which is on the high side as it means it would take AORT, 12.48 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of AORT (12.48) is better than 71.89% of its industry peers.
A Debt/Equity ratio of 0.50 indicates that AORT is not too dependend on debt financing.
The Debt to Equity ratio of AORT (0.50) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.5 | ||
| Debt/FCF | 12.48 | ||
| Altman-Z | 4.02 |
ROIC/WACC0.27
WACC8.46%
2.3 Liquidity
A Current Ratio of 3.93 indicates that AORT has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 3.93, AORT is in the better half of the industry, outperforming 67.57% of the companies in the same industry.
A Quick Ratio of 2.88 indicates that AORT has no problem at all paying its short term obligations.
AORT's Quick ratio of 2.88 is fine compared to the rest of the industry. AORT outperforms 63.78% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.93 | ||
| Quick Ratio | 2.88 |
3. Growth
3.1 Past
AORT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -85.71%.
Looking at the last year, AORT shows a quite strong growth in Revenue. The Revenue has grown by 9.81% in the last year.
Measured over the past years, AORT shows a small growth in Revenue. The Revenue has been growing by 7.06% on average per year.
EPS 1Y (TTM)-85.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%220%
Revenue 1Y (TTM)9.81%
Revenue growth 3Y9.14%
Revenue growth 5Y7.06%
Sales Q2Q%16.3%
3.2 Future
AORT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 46.17% yearly.
The Revenue is expected to grow by 11.94% on average over the next years. This is quite good.
EPS Next Y148.8%
EPS Next 2Y75.22%
EPS Next 3Y53.35%
EPS Next 5Y46.17%
Revenue Next Year12.7%
Revenue Next 2Y11.83%
Revenue Next 3Y11.75%
Revenue Next 5Y11.94%
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
AORT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 101.90, the valuation of AORT can be described as expensive.
Based on the Price/Forward Earnings ratio, AORT is valued a bit cheaper than the industry average as 65.95% of the companies are valued more expensively.
AORT's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 24.03.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 101.9 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AORT indicates a somewhat cheap valuation: AORT is cheaper than 65.95% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, AORT is valued a bit cheaper than the industry average as 68.65% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 126.92 | ||
| EV/EBITDA | 52.32 |
4.3 Compensation for Growth
AORT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as AORT's earnings are expected to grow with 53.35% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y75.22%
EPS Next 3Y53.35%
5. Dividend
5.1 Amount
No dividends for AORT!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
46.89
-0.29 (-0.61%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners87.11%
Inst Owner ChangeN/A
Ins Owners4.19%
Ins Owner Change-5.25%
Market Cap2.22B
Revenue(TTM)422.65M
Net Income(TTM)-9.12M
Analysts83.08
Price Target52.75 (12.5%)
Short Float %2.76%
Short Ratio3.29
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1085.72%
Min EPS beat(2)243.19%
Max EPS beat(2)1928.24%
EPS beat(4)3
Avg EPS beat(4)431.47%
Min EPS beat(4)-537.25%
Max EPS beat(4)1928.24%
EPS beat(8)6
Avg EPS beat(8)226.74%
EPS beat(12)8
Avg EPS beat(12)127.86%
EPS beat(16)11
Avg EPS beat(16)63.37%
Revenue beat(2)1
Avg Revenue beat(2)0.73%
Min Revenue beat(2)-1.12%
Max Revenue beat(2)2.59%
Revenue beat(4)2
Avg Revenue beat(4)-0.44%
Min Revenue beat(4)-5.37%
Max Revenue beat(4)2.59%
Revenue beat(8)4
Avg Revenue beat(8)0.31%
Revenue beat(12)7
Avg Revenue beat(12)0.63%
Revenue beat(16)10
Avg Revenue beat(16)0.6%
PT rev (1m)14.27%
PT rev (3m)21.97%
EPS NQ rev (1m)-13.05%
EPS NQ rev (3m)19.99%
EPS NY rev (1m)86.52%
EPS NY rev (3m)81.82%
Revenue NQ rev (1m)0.26%
Revenue NQ rev (3m)0.72%
Revenue NY rev (1m)0.92%
Revenue NY rev (3m)0.86%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 101.9 | ||
| P/S | 5.26 | ||
| P/FCF | 126.92 | ||
| P/OCF | 72.92 | ||
| P/B | 5.06 | ||
| P/tB | 79.73 | ||
| EV/EBITDA | 52.32 |
EPS(TTM)-0.26
EYN/A
EPS(NY)0.46
Fwd EY0.98%
FCF(TTM)0.37
FCFY0.79%
OCF(TTM)0.64
OCFY1.37%
SpS8.92
BVpS9.26
TBVpS0.59
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.06% | ||
| ROE | -2.08% | ||
| ROCE | 2.88% | ||
| ROIC | 2.28% | ||
| ROICexc | 2.52% | ||
| ROICexgc | 6.11% | ||
| OM | 5.26% | ||
| PM (TTM) | N/A | ||
| GM | 64.5% | ||
| FCFM | 4.14% |
ROA(3y)-2.68%
ROA(5y)-2.4%
ROE(3y)-7.46%
ROE(5y)-6.47%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y40.9%
ROICexgc growth 5Y5.66%
ROICexc growth 3Y48.24%
ROICexc growth 5Y9.09%
OM growth 3Y34.21%
OM growth 5Y6.88%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.05%
GM growth 5Y-0.68%
F-Score5
Asset Turnover0.49
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.5 | ||
| Debt/FCF | 12.48 | ||
| Debt/EBITDA | 4.81 | ||
| Cap/Depr | 56.35% | ||
| Cap/Sales | 3.07% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 67.34% | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.93 | ||
| Quick Ratio | 2.88 | ||
| Altman-Z | 4.02 |
F-Score5
WACC8.46%
ROIC/WACC0.27
Cap/Depr(3y)42.06%
Cap/Depr(5y)43.23%
Cap/Sales(3y)2.8%
Cap/Sales(5y)3.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-85.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%220%
EPS Next Y148.8%
EPS Next 2Y75.22%
EPS Next 3Y53.35%
EPS Next 5Y46.17%
Revenue 1Y (TTM)9.81%
Revenue growth 3Y9.14%
Revenue growth 5Y7.06%
Sales Q2Q%16.3%
Revenue Next Year12.7%
Revenue Next 2Y11.83%
Revenue Next 3Y11.75%
Revenue Next 5Y11.94%
EBIT growth 1Y-25.58%
EBIT growth 3Y46.49%
EBIT growth 5Y14.43%
EBIT Next Year115.81%
EBIT Next 3Y44.55%
EBIT Next 5Y34.17%
FCF growth 1Y4464.09%
FCF growth 3YN/A
FCF growth 5Y7.33%
OCF growth 1Y292.01%
OCF growth 3YN/A
OCF growth 5Y7.04%
ARTIVION INC / AORT FAQ
Can you provide the ChartMill fundamental rating for ARTIVION INC?
ChartMill assigns a fundamental rating of 5 / 10 to AORT.
Can you provide the valuation status for ARTIVION INC?
ChartMill assigns a valuation rating of 4 / 10 to ARTIVION INC (AORT). This can be considered as Fairly Valued.
Can you provide the profitability details for ARTIVION INC?
ARTIVION INC (AORT) has a profitability rating of 4 / 10.
Can you provide the financial health for AORT stock?
The financial health rating of ARTIVION INC (AORT) is 6 / 10.